BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

437 related articles for article (PubMed ID: 15099518)

  • 1. Different EZH2-containing complexes target methylation of histone H1 or nucleosomal histone H3.
    Kuzmichev A; Jenuwein T; Tempst P; Reinberg D
    Mol Cell; 2004 Apr; 14(2):183-93. PubMed ID: 15099518
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of histone H3 lysine 27 methylation in Polycomb-group silencing.
    Cao R; Wang L; Wang H; Xia L; Erdjument-Bromage H; Tempst P; Jones RS; Zhang Y
    Science; 2002 Nov; 298(5595):1039-43. PubMed ID: 12351676
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Substrate preferences of the EZH2 histone methyltransferase complex.
    Martin C; Cao R; Zhang Y
    J Biol Chem; 2006 Mar; 281(13):8365-70. PubMed ID: 16431907
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Silencing of human polycomb target genes is associated with methylation of histone H3 Lys 27.
    Kirmizis A; Bartley SM; Kuzmichev A; Margueron R; Reinberg D; Green R; Farnham PJ
    Genes Dev; 2004 Jul; 18(13):1592-605. PubMed ID: 15231737
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Polycomb Ezh2 methyltransferase regulates muscle gene expression and skeletal muscle differentiation.
    Caretti G; Di Padova M; Micales B; Lyons GE; Sartorelli V
    Genes Dev; 2004 Nov; 18(21):2627-38. PubMed ID: 15520282
    [TBL] [Abstract][Full Text] [Related]  

  • 6. SUZ12 is required for both the histone methyltransferase activity and the silencing function of the EED-EZH2 complex.
    Cao R; Zhang Y
    Mol Cell; 2004 Jul; 15(1):57-67. PubMed ID: 15225548
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Composition and histone substrates of polycomb repressive group complexes change during cellular differentiation.
    Kuzmichev A; Margueron R; Vaquero A; Preissner TS; Scher M; Kirmizis A; Ouyang X; Brockdorff N; Abate-Shen C; Farnham P; Reinberg D
    Proc Natl Acad Sci U S A; 2005 Feb; 102(6):1859-64. PubMed ID: 15684044
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Histone deacetylase inhibitors deplete enhancer of zeste 2 and associated polycomb repressive complex 2 proteins in human acute leukemia cells.
    Fiskus W; Pranpat M; Balasis M; Herger B; Rao R; Chinnaiyan A; Atadja P; Bhalla K
    Mol Cancer Ther; 2006 Dec; 5(12):3096-104. PubMed ID: 17172412
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Suz12 is essential for mouse development and for EZH2 histone methyltransferase activity.
    Pasini D; Bracken AP; Jensen MR; Lazzerini Denchi E; Helin K
    EMBO J; 2004 Oct; 23(20):4061-71. PubMed ID: 15385962
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Biophysical characterization of histone H3.3 K27M point mutation.
    Hetey S; Boros-Oláh B; Kuik-Rózsa T; Li Q; Karányi Z; Szabó Z; Roszik J; Szalóki N; Vámosi G; Tóth K; Székvölgyi L
    Biochem Biophys Res Commun; 2017 Aug; 490(3):868-875. PubMed ID: 28647357
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular and functional mapping of EED motifs required for PRC2-dependent histone methylation.
    Montgomery ND; Yee D; Montgomery SA; Magnuson T
    J Mol Biol; 2007 Dec; 374(5):1145-57. PubMed ID: 17997413
    [TBL] [Abstract][Full Text] [Related]  

  • 12. mAM facilitates conversion by ESET of dimethyl to trimethyl lysine 9 of histone H3 to cause transcriptional repression.
    Wang H; An W; Cao R; Xia L; Erdjument-Bromage H; Chatton B; Tempst P; Roeder RG; Zhang Y
    Mol Cell; 2003 Aug; 12(2):475-87. PubMed ID: 14536086
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A model for transmission of the H3K27me3 epigenetic mark.
    Hansen KH; Bracken AP; Pasini D; Dietrich N; Gehani SS; Monrad A; Rappsilber J; Lerdrup M; Helin K
    Nat Cell Biol; 2008 Nov; 10(11):1291-300. PubMed ID: 18931660
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Binding of different histone marks differentially regulates the activity and specificity of polycomb repressive complex 2 (PRC2).
    Xu C; Bian C; Yang W; Galka M; Ouyang H; Chen C; Qiu W; Liu H; Jones AE; MacKenzie F; Pan P; Li SS; Wang H; Min J
    Proc Natl Acad Sci U S A; 2010 Nov; 107(45):19266-71. PubMed ID: 20974918
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inner workings and regulatory inputs that control Polycomb repressive complex 2.
    O'Meara MM; Simon JA
    Chromosoma; 2012 Jun; 121(3):221-34. PubMed ID: 22349693
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Selective interactions between vertebrate polycomb homologs and the SUV39H1 histone lysine methyltransferase suggest that histone H3-K9 methylation contributes to chromosomal targeting of Polycomb group proteins.
    Sewalt RG; Lachner M; Vargas M; Hamer KM; den Blaauwen JL; Hendrix T; Melcher M; Schweizer D; Jenuwein T; Otte AP
    Mol Cell Biol; 2002 Aug; 22(15):5539-53. PubMed ID: 12101246
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of the polycomb protein EED in the propagation of repressive histone marks.
    Margueron R; Justin N; Ohno K; Sharpe ML; Son J; Drury WJ; Voigt P; Martin SR; Taylor WR; De Marco V; Pirrotta V; Reinberg D; Gamblin SJ
    Nature; 2009 Oct; 461(7265):762-7. PubMed ID: 19767730
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Down-regulation of human DAB2IP gene expression mediated by polycomb Ezh2 complex and histone deacetylase in prostate cancer.
    Chen H; Tu SW; Hsieh JT
    J Biol Chem; 2005 Jun; 280(23):22437-44. PubMed ID: 15817459
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Regulation of histone methylation by automethylation of PRC2.
    Wang X; Long Y; Paucek RD; Gooding AR; Lee T; Burdorf RM; Cech TR
    Genes Dev; 2019 Oct; 33(19-20):1416-1427. PubMed ID: 31488576
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of hPHF1 in H3K27 methylation and Hox gene silencing.
    Cao R; Wang H; He J; Erdjument-Bromage H; Tempst P; Zhang Y
    Mol Cell Biol; 2008 Mar; 28(5):1862-72. PubMed ID: 18086877
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.